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Abstract
Background: The sphingolipids galactosylceramide (GalCer) and sulfatide are major myelin components and are
thought to play important roles in myelin function. The importance of GalCer and sulfatide has been validated
using UDP-galactose:ceramide galactosyltransferase-deficient (Cgt
-/-) mice, which are impaired in myelin
maintenance. These mice, however, are still able to form compact myelin. Loss of GalCer and sulfatide in these
mice is accompanied by up-regulation of 2-hydroxylated fatty acid containing (HFA)-glucosylceramide in myelin.
This was interpreted as a partial compensation of the loss of HFA-GalCer, which may prevent a more severe myelin
phenotype. In order to test this hypothesis, we have generated Cgt
-/- mice with an additional deletion of the fatty
acid 2-hydroxylase (Fa2h) gene.
Results: Fa2h
-/-/Cgt
-/- double-deficient mice lack sulfatide, GalCer, and in addition HFA-GlcCer and sphingomyelin.
Interestingly, compared to Cgt
-/- mice the amount of GlcCer in CNS myelin was strongly reduced in Fa2h
-/-/Cgt
-/-
mice by more than 80%. This was accompanied by a significant increase in sphingomyelin, which was the
predominant sphingolipid in Fa2h
-/-/Cgt
-/- mice. Despite these significant changes in myelin sphingolipids, compact
myelin was formed in Fa2h
-/-/Cgt
-/- mice, and g-ratios of myelinated axons in the spinal cord of 4-week-old Fa2h
-/-/
Cgt
-/- mice did not differ significantly from that of Cgt
-/- mice, and there was no obvious phenotypic difference
between Fa2h
-/-/Cgt
-/- and Cgt
-/- mice
Conclusions: These data show that compact myelin can be formed with non-hydroxylated sphingomyelin as the
predominant sphingolipid and suggest that the presence of HFA-GlcCer and HFA-sphingomyelin in Cgt
-/- mice
does not functionally compensate the loss of HFA-GalCer.
Background
Galactosylceramide (GalCer) is the most abundant
sphingolipid of mammalian myelin [1]. It is synthesized
in the endoplasmic reticulum by UDP-galactose:cera-
mide galactosyltransferase (encoded by the Cgt gene). In
the Golgi apparatus, part of the GalCer is sulfated by
cerebroside sulfotransferase (encoded by the Gal3st1
gene), forming sulfatide [2] (see Figure 1). In the
absence of a functional Cgt gene, compact myelin can
be formed, which is, however, unstable and Cgt
-/- mice
develop tremors and ataxia at 3 to 4 weeks of age [3,4].
This phenotype could be explained by disturbed axon-
glial contacts at the paranodes in the CNS caused by
mistargeting of essential adhesion molecules, NF-155
and Caspr [5,6]. At least in part, these structural altera-
tions are caused by the loss of sulfatide rather than Gal-
Cer, as demonstrated by a similar alteration of the
paranodal region in Gal3st1-deficient mice, which lack
sulfatide but have normal GalCer levels [7]. However,
myelin appear to be more stable in Gal3st1-deficient
mice, suggesting additional, yet less defined roles of
GalCer in myelin [8].
In Cgt
-/- mice, the loss of GalCer and sulfatide is accom-
panied by a significant upregulation of 2-hydroxylated
fatty acid-containing (HFA) glucosylceramide (HFA-
GlcCer) and HFA-sphingomyelin [3,4]. Interestingly, there
are no indications for presence of HFA-gangliosides or
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any medium, provided the original work is properly cited.other higher glycosylated HFA-sphingolipids in the brain
of Cgt
-/- mice [9]. The presence of HFA-GlcCer and HFA-
sphingomyelin was interpreted as a compensatory upregu-
lation, which may also (in part) functionally replace HFA-
GalCer, enabling Cgt
-/- mice to form compact myelin
[3,10].
HFA-sphingolipids in CNS and PNS myelin are
s y n t h e s i z e df r o m2 - h y d r o x y l a t e df a t t ya c i d s ,f o r m e db y
the fatty acid 2-hydroxylase (encoded by the Fa2h gene)
[11-14]. Although loss of 2-hydroxylated sphingolipids
in myelin does not affect initial myelin formation, it
causes late onset (in mice older than 6 months) axon
and myelin sheath degeneration [15]. Fa2h-deficiency
was identified as the cause of a new leukodystrophy
with spastic paraparesis [16], and hereditary spastic
paraplegia SPG35 [17], respectively.
In order to test the hypothesis that the presence of
HFA-GlcCer and HFA-sphingomyelin in Cgt
-/- mice is a
functional important compensatory upregulation, pre-
venting a more severe phenotype, we generated Cgt
-/-
mice with an additional deficiency in the Fa2h gene.
Our analysis shows that the additional deletion of Fa2h
does not obviously affect the phenotype of Cgt
-/- mice.
This suggests that HFA-GlcCer and HFA-sphingomyelin
do not functionally compensate the loss of HFA-GalCer
in Cgt
-/- mice.
Results
Generation of Fa2h
-/-/Cgt
-/- double deficient mice
In order to test the hypothesis that HFA-GlcCer par-
tially compensates the loss of HFA-GalCer in Cgt
-/-
mice and thereby prevents a more severe phenotype, we
generated Cgt
-/- mice with an additional deficiency in
Fa2h. As shown previously, young Fa2h
-/- mice form
structural and functional normal myelin [15] and did
not show behavioral abnormalities that would indicate
myelin deficiency. Older Fa2h
-/-, however, developed a
progressive axonal degeneration in peripheral nerves
and brainstem, accompanied by myelin sheath degenera-
tion [15]. As shown before [3,4], Cgt
-/- mice had a
strongly reduced life span, whereas Fa2h
-/- mice did not
show increased mortality (data not shown). Survival of
Fa2h
-/-/Cgt
-/- double deficient mice was not significant
different from Cgt
-/- mice (around 50% survival at four
weeks of age). There were no obvious behavioral differ-
ences between the two genotypes. However, because of
the low amount of age-/weight- and gender-matched 4-
week-old Cgt
-/- and Fa2h
-/-/Cgt
-/- mice available, exten-
sive behavioral testing could not be performed, and thus
minor behavioral differences between Cgt
-/- and Fa2h
-/-/
Cgt
-/- mice cannot be ruled out. The following biochem-
ical and morphological analyses were done with mice at
4 weeks of age.
GlcCer levels are reduced in CNS and PNS of Fa2h
-/-/Cgt
-/-
mice when compared to Cgt
-/- mice
TLC analysis of total brain lipids from wild-type, Fa2h
-/-,
Cgt
-/- and Fa2h
-/-/Cgt
-/-mice showed significant levels of
HFA-GlcCer in Cgt
-/-mice, in line with earlier reports
[3,4]. Unexpectedly, NFA-GlcCer levels in total brain of
Fa2h
-/-/Cgt
-/-mice were strongly reduced compared to
HFA-GlcCer levels in Cgt
-/- mice (Figure 2A). Presence
of NFA-GlcCer in Fa2h
-/-/Cgt
-/- mice was better visible
when the amount of lipids from these mice loaded was
increased 4-fold compared to controls (Figure 2B).
A similar reduction in GlcCer levels was seen when
sphingolipids of purified CNS myelin were examined
(Figure 3A). Densitometry revealed a reduction of NFA-
GlcCer by more than 80% compared to HFA-GlcCer
levels in Cgt
-/-mice (Figure 3C). Analysis of peripheral
nerves (sciatic nerve) revealed a reduction of GlcCer in
Fa2h
-/-/Cgt
-/- mice by about 60% compared to Cgt
-/-mice
(Figure 3B, D). MALDI-TOF mass spectrometry of hexo-
sylceramides from Cgt
-/- and Fa2h
-/-/Cgt
-/- mice (CNS
myelin) demonstrated that cerebrosides in both geno-
types mainly contained very long chain fatty acyl
( V L C F A ;C 2 2 : 0 ,C 2 4 : 0 ,a n dC 2 4 : 1 )r e s i d u e s( d a t an o t
shown). The TLC analysis also revealed a strong increase
in the very-long chain fatty acid (VLCFA)-containing
sphingomyelin (SM; upper band) in Fa2h
-/-/Cgt
-/-,b u t
also in Fa2h
-/-/Cgt
+/- mice, when compared to Cgt
-/- and
wild-type mice (note that Fa2h
-/- mice heterozygous for
Cgt were used as a control in these experiments, because
the number of Fa2h
-/-/Cgt
+/+ mice were limited). Densi-
tometry confirmed a 2-fold increase of sphingomyelin in
CNS myelin of Fa2h
-/-/Cgt
-/- mice compared to wild-type
controls (and 60% increase in Fa2h
-/-/Cgt
+/- mice; Fa2h
-/-
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Figure 1 Pathway of sphingolipid biosynthesis in myelinating
glia cells. Changes in sphingolipids observed in Cgt
-/- mice (blue
arrows) and expected possible changes in Fa2h
-/-/Cgt
-/- mice (red
arrows). Shown are the genetic symbols of genes encoding the
respective enzymes: Cgt, UDP-galactose:ceramide
galactosyltransferase; CerS, ceramide synthase; Des1,
dihydroceramide desaturase; Fa2h, fatty acid 2-hydroxylase; Gal3st1,
galactose-3-O-sulfotransferase 1; Sgms, sphingomyelin synthase;
Ugcg, UDP-glucose ceramide glucosyltransferase.
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myelin in the PNS was about 50% in Fa2h
-/-/Cgt
-/- mice
(Figure 3F).
In line with data published by Bosio et al. [18], HFA-
ceramide was detectable in Cgt
-/- mice but not in mice
of other genotypes (Figure 4A). However, in contrast to
the 18-day-old Cgt
-/- mice analyzed by Saadat et al. [19],
we did not observe a strong increase of ceramide in 4-
week-old Cgt
-/- mice compared to wild-type controls.
This might be due to the different ages examined.
To examine the possibility that GlcCer was replaced by
gangliosides in myelin of Fa2h
-/-/Cgt
-/- mice, gangliosides
were isolated and analyzed by TLC. Although the total
amount of gangliosides in the myelin fraction of Fa2h
-/-/
Cgt
-/- and Cgt
-/- mice was increased compared to wild-
type, the major myelin ganglioside GM1 was unchanged
and only gangliosides normally found in neuronal mem-
branes (GD1a, GD1b, GT1b) were increased (Figure 4B).
Most likely these gangliosides are derived from neuronal
membranes and possibly reflect a higher proportion of
neuronal membrane contaminations in the Cgt
-/- and
Fa2h
-/-/Cgt
-/- mice, with their significant reduced
amounts of compact myelin. In line with this, Saadat
et al. [19] showed a similar relative composition of major
gangliosides in myelin preparation from mice deficient in
Ugcg in myelinating cells. We therefore believe that mye-
lin ganglioside levels in Fa2h
-/-/Cgt
-/- mice were not
increased compared to Cgt
-/- mice or wild-type controls.
I ns u m m a r y ,w ec o n c l u d et h a tH F A - G l c C e rp r e s e n ti n
Cgt
-/- CNS myelin was replaced by only low amounts of
NFA-GlcCer but larger amounts of NFA-sphingomyelin
in Fa2h
-/-/Cgt
-/- mice. Taken together, these results indi-
cate that myelin hexosylceramides were mainly replaced
by sphingomyelin in the absence of Fa2h expression. It
should be noted that the increase of sphingomyelin and
the decrease of hexosylceramides were more pronounced
in CNS myelin than in the PNS. This might indicate dif-
ferences between oligodendrocytes and Schwann cells in
the trafficking or metabolism of sphingolipids.
Myelination in Fa2h
-/-/Cgt
-/- mice as compared to Cgt
-/-
mice
Myelin content in the brain of Cgt
-/-, Fa2h
-/-/Cgt
-/-,a n d
wild-type mice was examined by Western blot analysis
of myelin basic protein (MBP) and by gravimetry of pur-
ified compact myelin. At the examined time point
(4 weeks of age), MBP levels were reduced in Cgt
-/- mice
compared to wild-type controls (Figure 5A), in agree-
ment with our previous observations [20]. A comparable
reduction of MBP was found in Fa2h
-/-/Cgt
-/- mice.
Accordingly, the amount of compact myelin isolated by
sucrose gradient centrifugation was significant reduced in
both, Fa2h
-/-/Cgt
-/- and Cgt
-/- mice, compared to wild-
type controls (Figure 5B), but there was no significant
difference between the first two genotypes.
Absence of GalCer and HFA-sphingolipids does not affect
stability of CHAPS-insoluble membrane fractions
C o m p a c tm y e l i no fw i l d - t y p em i c ei ss t a b l ea g a i n s t
extraction with the detergent CHAPS at low [21] and
high temperature [15]. Data by Simons et al. [21] suggest
that loss of HFA-GalCer in Cgt
-/- mice affects the asso-
ciation of the myelin proteolipid protein (PLP) with
CHAPS-insoluble membrane fractions (CIMF), suggest-
ing a role for (HFA-)GalCer in the formation or stabiliza-
tion of CIMF. We have recently shown that the absence
of HFA-sphingolipids does not affect stability of myelin
CIMF [15]. However, in order to examine a possible
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Figure 2 Brain lipid analysis of Fa2h
-/-/Cgt
-/- mice. (A) TLC analysis of sphingolipids (after mild alkaline hydrolysis) from total brain of 4-week-
old animals of the indicated genotypes showed a strong reduction of GlcCer in Fa2h
-/-/Cgt
-/- (lane 3) compared to Cgt
-/- mice (lane 2). The
amount of lipids isolated from 0.05 mg of tissue (wet weight) was loaded per lane. LPE, lyso-phosphatidylethanolamine; SM, sphingomyelin. (B)
TLC analysis of total brain lipids (not subjected to alkaline hydrolysis). In order to demonstrate the presence of NFA-GlcCer in Fa2h
-/-/Cgt
-/- mice,
the amounts of lipids was increased 4-fold in case of Fa2h
-/-/Cgt
-/- mice.
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Figure 3 Myelin lipid analysis of Fa2h
-/-/Cgt
-/- mice. (A) TLC analysis of lipids extracted from purified myelin confirmed the low concentration
of NFA-GlcCer in Fa2h
-/-/Cgt
-/- mice and showed that myelin from Fa2h
-/-/Cgt
-/- mice contained larger amounts of NFA-sphingomyelin (lane 3)
compared to wild-type (lane 1) or Cgt
-/- mice (lane 2). Lipid samples were subjected to alkaline hydrolysis before TLC. LPE, lyso-
phosphatidylethanolamine; SM, sphingomyelin. (B) Total lipids were isolated from sciatic nerves of 4-week-old mice of the indicated genotypes
and separated by HPTLC. Shown are 2 representative chromatograms (Note that lanes 5 to 8 are from the same TLC plate, however, 2 lanes
containing lipids from mice with other genotypes have been removed from the Figure). PE, phosphatidylethanolamine. Hexosylceramide
(HexCer) (C, D) and sphingomyelin levels (E, F) in CNS myelin (C, E) and sciatic nerves (D, F) were determined by densitometric scanning of
HPTLC plates. HexCer levels were normalized to cholesterol. Data were combined from three independent experiments, and lipids from 3-6
animals per genotype were analyzed. Shown are the mean ± SD (CNS myelin: n = 3-5; sciatic nerves: n = 4-6); asterisks indicate statistically
significant differences (ANOVA with post hoc Fisher’s LSD test, *p < 0.05).
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myelin of Fa2h
-/-/Cgt
-/- mice was subjected to CHAPS
extraction at 37°C. Optiprep gradient centrifugations
were performed and the fractions were examined
for sphingolipid content, as described [15]. These experi-
m e n t ss h o w e dt h a tm y e l i nw a sr e s i s t a n tt oC H A P S
extraction irrespective of the genotype (Figure 6).
Therefore, we conclude that neither GalCer nor HFA-
sphingolipids are essential for stabilization of CIMF.
Comparable myelination in Fa2h
-/-/Cgt
-/- and Cgt
-/- mice
To evaluate the extent of myelin sheaths thickness, cross
sections were obtained from the cervical spinal cord of
4-week-old mice. On each side of the midline, starting
at the deep medial boundary of the ventral funiculus
and extending ventrally and laterally, fibers of all cali-
bers were included. In this unbiased sampling approach,
the number of myelinated axons was unchanged in
Cgt
-/- and Fa2h
-/-/Cgt
-/- mice (179 ± 19 versus 194 ±
30). Only few axons in both mouse mutants displayed
no myelin at this postnatal stage (Figure 7A). The mean
axon diameter did not differ significantly between Cgt
-/-
and Fa2h
-/-/Cgt
-/- mice (3.88 μmv e r s u s3 . 7 7μm). The
axons of Fa2h
-/-/Cgt
-/- mice recruit inappropriately thick
myelin relative to their absolute calibers resulting in an
average myelin thickness of 0.60 ± 0.02 μmv e r s u s
0.53 ± 0.01 μmi nCgt
-/- (p < 0.01, Chi-Square test, n =
3) (Figure 7B). However, due to the relative small differ-
ence in myelin thickness, the g-ratios did not differ sig-
nificantly between the two genotypes (Figure 7C).
Furthermore, electron microscopy of myelinated axons
revealed normal compact myelin in Fa2h
-/-/Cgt
-/- mice
(Figure 7D). These results demonstrate that a compact
myelin sheath can be generated in the absence of
GalCer and any 2-hydroxylated sphingolipids.
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Figure 4 TLC analysis of ceramides and gangliosides. (A) TLC analysis of free ceramides in myelin confirmed the presence of HFA-ceramide
in Cgt
-/- (lane 2) and its absence in Fa2h
-/-/Cgt
-/- myelin (lane 3). NFA-ceramide levels were slightly increased in Fa2h
-/-/Cgt
-/- mice (lane 3). Cer,
ceramide. (B) The ganglioside pattern of purified myelin was not altered in Fa2h
-/-/Cgt
-/- (lanes 1 and 2) compared to Cgt
-/- mice (lanes 3 and 4).
The same amount of the major myelin ganglioside GM1 was found in both mouse lines, as well as in wild-type controls (lanes 5 and 6). The
larger amount of the gangliosides GD1a, GD1b, and GT1b, which are major gangliosides of neuronal membranes, in the two mouse lines with
less compact myelin are most likely caused by a higher proportion of axonal membranes in the myelin preparation.
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Figure 5 Reduced levels of MBP and compact myelin in Fa2h
-/-/
Cgt
-/- and Cgt
-/- mice. (A) Western blot analysis of 4-week-old wild-
type (lanes 1 and 2), Cgt
-/- (lanes 3 and 4), and Fa2h
-/-/Cgt
-/- mice
(lanes 5 and 6) brain homogenates showed reduced MBP levels in
Cgt
-/- and Fa2h
-/-/Cgt
-/- mice. Shown is one representative out of
three independent experiments, all of which gave comparable
results. (B) The dry weight of purified myelin per mg brain wet
weight isolated from Cgt
-/- and Fa2h
-/-/Cgt
-/- mice (n = 3 per
genotype) was significantly reduced compared to wild-type controls
(*p < 0.05, t-test).
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drocytes of Fa2h
-/-/Cgt
-/- and Cgt
-/- were observed by
the histological or electron microscopic analyses, how-
ever, a detailed structural analysis was not performed,
and therefore we cannot exclude subtle structural
changes in Fa2h
-/-/Cgt
-/- when compared to Cgt
-/- mice
(e.g. in the paranodal region).
Discussion
Although HFA-sphingolipids appear to be dispensable
for the formation of compact myelin [15], they are
essential for long-term myelin maintenance and may
also play a role in glia-dependent axonal support. In the
absence of GalCer in Cgt
-/- mice, compact myelin can
be formed [3,4], which is, however, unstable, also sug-
gesting a role of GalCer in myelin maintenance. We
hypothesized that HFA-sphingolipids may also play a
more subtle role in early postnatal development, which
could be detectable on a Cgt
-/- background, where com-
pact but less stable myelin is formed. However, we did
not observe signs of a more severe phenotype in
Fa2h
-/-/Cgt
-/- mice compared to Cgt
-/- mice. At the
behavioral level, Cgt
-/- and Fa2h
-/-/Cgt
-/- mice were
indistinguishable. Though there was a shift towards
thicker myelin in Fa2h
-/-/Cgt
-/- compared to Cgt
-/- mice,
the g-ratios did not differ significantly between Cgt
-/-
and Fa2h
-/-/Cgt
-/- mice. Furthermore, myelin from
Fa2h
-/-/Cgt
-/- and Cgt
-/- mice was resistant towards
extraction with CHAPS, as shown before for Fa2h
-/- and
wild-type mice [15].
Unexpectedly, HFA-GlcCer present in Cgt
-/- mice was
replaced by only low amounts of NFA-GlcCer in Fa2h
-/-/
Cgt
-/- mice but higher levels of NFA-sphingomyelin. This
suggests that the GlcCer concentration in myelin is not
critical and furthermore that elevated GlcCer levels in
Cgt
-/- mice do not functionally compensate loss of Gal-
Cer. Accordingly, Saadat et al. [19] showed that deleting
oligodendroglial glucosylceramide synthase (Ugcg)i n
Cgt
-/- mice did not reinforce the myelin phenotype. This
demonstrates that upregulation of (HFA)-GlcCer in
Cgt
-/- mice does not functionally compensate loss of
GalCer in these mice. In Ugcg-deficient Cgt
-/- mice, HFA-
GlcCer was partially replaced by HFA-sphingomyelin
[19]. Our results demonstrate that HFA-sphingomyelin
can be replaced by NFA-sphingomyelin without any
obvious effect on the phenotype of Cgt
-/- mice. Thus, the
significant up-regulation of HFA-sphingomyelin in Cgt
-/-
mice is not a functional compensation.
The reason for the much lower NFA-GlcCer level in
CNS myelin of Fa2h
-/-/Cgt
-/- mice compared to the
HFA-GlcCer level in Cgt
-/- mice is currently unknown.
One possible explanation for the high HFA-GlcCer level
and absence of HFA-gangliosides [9] in Cgt
-/- mice
could be the inability of the responsible glycosyltrans-
ferases to use HFA-GlcCer as a substrate. However, pre-
sence of a high amount of HFA-gangliosides in other
tissues [22] and in tumor cells [23] argues against this.
An alternative explanation could be differential sorting
of HFA- and NFA-GlcCer, as shown for polarized
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Sulfatide
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Fa2h /Cgt
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Figure 6 CHAPS-insoluble membrane fractions in Fa2h
-/-/Cgt
-/-
myelin. Myelin from wild-type (Fa2h
+/+/Cgt
+/+) (A), Fa2h
+/-/Cgt
-/- (B),
and Fa2h
-/-/Cgt
-/- (C) mice isolated by sucrose density gradient
centrifugation was treated with 20 mM CHAPS at 37°C for 30 min,
followed by Optiprep density gradient centrifugation. Gradient
fractions were collected from the top, and total lipids were
extracted from all gradient fractions and separated by TLC. Most
membrane lipids were present in the CHAPS-insoluble membrane
fractions (CIMF), independent of the mouse genotype. Positions of
lipid standards are indicated. These experiments have been done
two times using two independent myelin preparations with similar
results. PE, phosphatidylethanolamine; SM, sphingomyelin.
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sphingolipids.
Although structural changes at the paranodes of Cgt
-/-
mice are clearly caused by sulfatide rather than GalCer
deficiency [7,25], myelin appear to be much more stable
in young adult gal3st1-deficient mice, whereas myelin
maintenance is already affected in young Cgt
-/- mice [8],
indicating additional function roles of HFA- and/or
NFA-GalCer. Taken together, our results and those of
Saadat et al. [19] strongly suggest that the upregulation
Figure 7 Normal lamellar spacing in Fa2h
-/-/Cgt
-/- myelin. (A) Typical cross sections of spinal cords from Cgt
-/- and Fa2h
-/-/Cgt
-/-mice (two
different magnifications are shown). Arrows indicate axons with thin or without myelin. Asterisks indicate demyelinated axons. Scale bar, 40 μm
(upper panel) 10 μm (lower panel). Myelin thickness (B) and g-ratios (C) were determined in the spinal cord of three mice per genotype. Though
there was a shift towards increased myelin thickness in Fa2h
-/-/Cgt
-/- compared to Cgt
-/- mice (Data shown are the mean SD [n = 3 animals per
genotype]; **p < 0.01, Chi-Square test), the g-ratios of myelinated axons were similar in Cgt
-/- and Fa2h
-/-/Cgt
-/- mice. (D) Electron micrographs
showing normal compact myelin in Fa2h
-/-/Cgt
-/- mice (Magnification: 16,000×). Scale bar, 50 nm.
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does not functionally compensate the loss of HFA-
GalCer in these mice. This, however, does not exclude
the possibility that GalCer could be functionally
replaced by GlcCer, if the latter would be present at
higher concentrations than in Cgt
-/- mice. The HFA-
GlcCer concentration in Cgt
-/- mice is clearly below the
concentration of HFA-GalCer in wild-type but also in
heterozygous Cgt
+/- mice (which show a wild-type phe-
notype). There might be a relatively high threshold of
hexosylceramide concentration in myelin to efficiently
fulfill its role in myelin maintenance. This possibility
could be tested using transgenic mice overexpressing
Ugcg under control of an oligodendrocyte specific pro-
moter, which to our knowledge are not available yet.
Alternatively, the functional role of HFA- and/or NFA-
GalCer may not be taken over by GlcCer or other
glycolipids.
Conclusions
Our data indicate that compact myelin can be formed
with non-hydroxylated sphingomyelin as the predomi-
nant sphingolipid, though myelin maintenance is
impaired. While the specific role of GalCer in myelin
maintenance remains mysterious, our results suggest
that the presence of HFA-GlcCer and HFA-sphingomye-
lin in Cgt
-/- mice does not functionally compensate the
loss of HFA-GalCer.
Methods
Mice
Fa2h
-/- mice have been described previously [15]. Hetero-
zygous Cgt
+/- mice (kindly provided by Dr. Brian Popko,
University of Chicago) were crossed with Fa2h
-/- mice
and double heterozygous Fa2h
+/-/Cgt
+/- mice were
interbred or bred with Fa2h
-/-/Cgt
+/- mice to obtain mice
of all possible nine genotypes. Genotyping was done
using tail genomic DNA and the following oligonucleo-
tides. Fa2h genotyping: 5’-GCTCTTCTTCAAGAGC-
CATCC-3’,5 ’-GTGCTGTACCTCAGCTGGTC-3’.
5’-ATTCGCAGCGCATCGCCTTCTATC-3’,P C Rp r o -
ducts: 1045 bp for wild-type and 685 bp for the targeted
allele; Cgt genotyping: 5’-TTACCAAGGAGTTCAG-
CAAACC-3’,5 ’-CCTCTCAGAAGGCAGAGACATTG-
3’,5 ’-TCTGCACGAGACTAGTGAGACG-3’,P C R
products: 684 bp for wild-type and 820 bp for the tar-
geted allele. All animal experiments followed internation-
ally recognized guidelines and were approved by the
Landesamt für Natur, Umwelt und Verbraucherschutz,
Nordrhein-Westfalen, Germany.
Lipid extraction and thin layer chromatography
Total lipid extracts were prepared from brains, sciatic
nerves, or purified myelin (from 4-week-old animals)
according to Bligh and Dyer [26]. In some experiments,
phosphoglycerolipids were removed by mild alkaline
hydrolysis as described [27]. In order to isolate ganglio-
sides from purified myelin, lipids were extracted as
described by Folch et al [28] and the ganglioside con-
taining upper phase was desalted by reversed-phase
chromatography using RP-18 columns (Merck, Darm-
stadt, Germany). Lipids were separated by thin layer
chromatography (TLC) in one of the following solvent
systems: (1) chloroform/methanol/water (65/25/4) for
hexosylceramides and sphingomyelin, (2) chloroform/
methanol/acetic acid (190/9/1) for ceramides, and (3)
chloroform/methanol/0.22% CaCl2 (60/35/4) to separate
gangliosides. HPTLC silica gel 60 plates (Merck) were
used for all experiments. To visualize lipids, HPTLC
plates were sprayed with cupric sulfate in aqueous phos-
phoric acid [27] followed by charring at 180°C for 5
min. Lipids were quantified by densitometry and the
GalCer and GlcCer levels were normalized to choles-
terol. Data are shown as the mean ± SD and were tested
for statistically significant differences by ANOVA with
post hoc Fisher’s least significant difference (LSD) test
using the program STATISTICA.
Isolation of myelin
Compact myelin was isolated by sucrose gradient centri-
fugation as described by Norton and Poduslo [29], with
minor modifications. Brains were homogenized in water
using an Ultra-Turrax tissue homogenizer (IKA-Werke,
Staufen, Germany). Aliquots of the homogenates were
used for lipid extraction. The residual homogenates
were adjusted to 10.5% (w/v) sucrose in 5 mM Tris-HCl
(pH 7.4) and overlaid onto 10 ml of 30% (w/v) sucrose
in 5 mM Tris-HCl (pH 7.4). After centrifugation
(68,000×g, 50 min, 4°C) the enriched myelin fraction
was recovered from the 10.5%/30% interphase, resus-
pended in 5 mM Tris-HCl (pH 7.4) and centrifuged at
68,000×g for 10 min. The resulting pellet was resus-
pended in 5 mM Tris-HCl (pH 7.4), centrifuged again,
and the myelin was further purified by a second sucrose
gradient centrifugation, followed by two washing steps
in 5 mM Tris-HCl (pH 7.4). The final myelin pellet was
resuspended in a small volume of water, lyophilized and
stored at -80°C.
Analysis of CHAPS insoluble membrane fractions
CHAPS insoluble membrane fractions (CIMF) of puri-
fied myelin were prepared by optiprep density gradient
centrifugation of myelin samples treated with 20 mM
CHAPS at 37°C, as described previously [15,21]. Six
fractions of 350 μl each were removed from the top of
the gradient and lipids were isolated from each fraction
according to Bligh and Dyer [26], and analyzed by TLC
as described above.
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MALDI-TOF MS of hexosylceramides was done as
described [13].
Western blotting
Brain samples were homogenized in 20 mM Tris-HCl
(pH 8.0), 150 mM NaCl (TBS), containing 5 mM EDTA
and 1 mM PMSF, using an Ultra-Turrax tissue homoge-
nizer (IKA-Werke, Staufen, Germany). Homogenates
were centrifuged at 1,000×g for 5 min and the superna-
tant was mixed with SDS-PAGE sample buffer contain-
ing 2-mercaptoethanol. Proteins were separated in
12.5%-polyacrylamide gels and transferred to nitrocellu-
lose membranes by semi-dry blotting. Membranes were
stained with rabbit anti-myelin basic protein (MBP; dilu-
tion 1:10,000; Millipore, Schwalbach, Germany) and
mouse anti-alpha-tubulin (Developmental Studies Hybri-
doma Bank, University of Iowa). Bound secondary anti-
bodies were detected by enhanced chemiluminescence
as described [30]. Protein concentrations were deter-
m i n e dw i t ht h eB i o - R a dD Cp r o t e i na s s a y( B i o - R a d
Laboratories, München, Germany) using bovine serum
albumin as standard.
Morphometrical analysis
Axon caliber and myelin thickness were measured on
toluidine-stained semithin sections of the cervical spinal
cord of 4-week-old mice. Axonal caliber was determined
by the diameter of a circle of area equivalent to each
axon. The g-ratio was determined by dividing the dia-
meter of the axon by the diameter of the fiber (axon
with myelin). Quantification of myelinated axons was
performed with a semi-automatic program on the basis
of AnalySIS using a light microscope (100× objective,
BX60, Olympus). All morphometric measurements were
conducted in a blinded manner using coded sections.
Ultrathin sections (50 nm) were photomicrographed
with an EM10 electron microscope (Zeiss, Germany) at
a magnification of 16.000×.
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